Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
OCRA Names Dmitriy Zamarin, MD, PhD, as 2026 Liz Tilberis Research Prize Winner
Dmitriy Zamarin, MD, PhD, has been awarded the 2026 Liz Tilberis Research Prize for Outstanding Early Career Investigators by Ovarian Cancer Research Alliance (OCRA). A physician-scientist whose research has explored new approaches to harnessing the immune system against ovarian cancer, Dr. Zamarin is Professor of Oncology, Section Head of Gynecologic Medical Oncology, and Co-Director of … Continued
OCRA Awards 2026 Rosalind Franklin Excellence in Ovarian Cancer Research Prize to Kenneth Nephew, PhD
Ovarian Cancer Research Alliance (OCRA) has named Kenneth Nephew, PhD, as the winner of the 2026 Rosalind Franklin Excellence in Ovarian Cancer Research Prize. For more than three decades, he has helped advance the field of ovarian cancer research through both his investigations into treatment resistance and his mentorship of others studying this disease. “Dr. … Continued
The Overview: October 2026
OCRA’s Rivkin Ovarian Cancer Research Symposium Convenes A Scientific Community Ready To Accelerate Progress More than 375 researchers, clinicians, and advocates gathered in Philadelphia for the 16th Biennial Rivkin Ovarian Cancer Research Symposium, presented for the first time by Ovarian Cancer Research Alliance (OCRA). Founded in 1996, the Symposium is the longest-standing meeting dedicated to … Continued